Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

for
Breast Cancer, Metastatic Breast Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT05524584

Phase 2, Recruiting

Immune Defense Protein Impact On Respiratory Immune Outcomes

for
Upper Respiratory Disease, Influenza,
Location: Los Angeles CA
Sponsor: Quantec Ltd

Sex: All

Age: 60+

Code: NCT07431840

Recruiting

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

for
Cancer-Associated Anorexia,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06995508

Phase 2, Recruiting

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

for
Human Papillomavirus-Negative Neck Squamous Cell Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06997094

Phase 1, Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer,
Location: Princeton NJ, Montreal
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07261631

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

for
Sickle Cell Disease, Measles Vaccination, Sickle Cell Anemia
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 6

Code: NCT07356050

Recruiting

PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

for
Estrogen-receptor-positive Breast Cancer,
Location: Boston MA
Sponsor: Kristina A. Fanucci

Sex: All

Age: 18+

Code: NCT07222215

Phase 2, Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Brewer ME, Lebanon NH, Stony Brook NY, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07195734

Phase 2, Recruiting

Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

for
HPV Vaccination
Location: Flint MI
Sponsor: Michigan State University

Sex: All

Age: 18+

Code: NCT07301905

Recruiting

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

for
Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-),
Location: New York NY, Long Island City NY, Grand Rapids MI,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07318805

Phase 1, Recruiting

PopSci CHW4CervixHealth

for
Cervical Cancer, Hpv, Human Papilloma Virus, HPV Infection
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: Female

Age: 25 - 65

Code: NCT07336134

Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Lebanon NH,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase 3, Recruiting

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

for
HPV Infection, HPV 16 Infection, High Risk HPV,
Location: New Haven CT, Akron OH, Minneapolis MN
Sponsor: Qurasense

Sex: Female

Age: 25+

Code: NCT07281599

Recruiting

Effect of Messaging on Pragmatic Outcomes Within an Integrated Healthcare System

for
Covid-19 Vaccination
Location: Pasadena CA
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT07838038

Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Burlington MA, Bridgeport CT, Brooklyn NY, Annapolis MD,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

for
Hepatitis B Virus (HBV), Lung Transplant Recipient
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07189377

Recruiting

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

for
Influenza, Human
Location: Hartsdale NY, Miami Lakes FL, Miami FL, Spartanburg SC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 64

Code: NCT07851246

Phase 3, Recruiting

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

for
Respiratory Tract Infection, Smell Disorder, Influenza,
Location: Bethesda MD
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All

Age: 18 - 70+

Code: NCT07149428

Recruiting

Breast Re-irradiation After Second Ipsilateral Lumpectomy

for
Breast Cancer, Cancer, Cancer of the Breast,
Location: Boca Raton FL, Miami FL
Sponsor: Youssef Zeidan

Sex: Female

Age: 40+

Code: NCT06867484

Recruiting

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

for
Influenza A, Influenza B, SAR-CoV-2,
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT07314905

Phase 3, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial